Listed

Hemab Therapeutics Holdings, Inc.

COAGNasdaqCIK 2114044HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$26.1m, Q2 FY2026
Net income−$24.1m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m14.1Research and development, period not labelled, three months to 2025-03-31$14.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure12.9Research and development, period not labelled, three months to 2025-06-30$12.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure19.5Research and development, Q1 FY2026, three months to 2026-03-31$19.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure20.3Research and development, Q2 FY2026, three months to 2026-06-30$20.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Selling, general and administrative$m2.5Selling, general and administrative, period not labelled, three months to 2025-03-31$2.5m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure3.2Selling, general and administrative, period not labelled, three months to 2025-06-30$3.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure4.2Selling, general and administrative, Q1 FY2026, three months to 2026-03-31$4.2m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure5.7Selling, general and administrative, Q2 FY2026, three months to 2026-06-30$5.7m. XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Operating income$m(16.6)Operating income, period not labelled, three months to 2025-03-31−$16.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(16.1)Operating income, period not labelled, three months to 2025-06-30−$16.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(23.6)Operating income, Q1 FY2026, three months to 2026-03-31−$23.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(26.1)Operating income, Q2 FY2026, three months to 2026-06-30−$26.1m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Income tax$m(0.2)Income tax, period not labelled, three months to 2025-03-31−$190.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure0.0Income tax, period not labelled, three months to 2025-06-30$4.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$12.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure0.1Income tax, Q2 FY2026, three months to 2026-06-30$97.0k. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Net income$m(15.3)Net income, period not labelled, three months to 2025-03-31−$15.3m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(12.2)Net income, period not labelled, three months to 2025-06-30−$12.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(22.7)Net income, Q1 FY2026, three months to 2026-03-31−$22.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(24.2)Net income, Q2 FY2026, three months to 2026-06-30−$24.1m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Diluted EPS$ per share(16.18)Diluted EPS, period not labelled, three months to 2025-03-31−$16.18 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(12.91)Diluted EPS, period not labelled, three months to 2025-06-30−$12.91 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(23.98)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$23.98 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(0.80)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Basic EPS$ per share(16.18)Basic EPS, period not labelled, three months to 2025-03-31−$16.18 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(12.91)Basic EPS, period not labelled, three months to 2025-06-30−$12.91 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(23.98)Basic EPS, Q1 FY2026, three months to 2026-03-31−$23.98 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(0.80)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.80 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure

Balance sheet

Cash and equivalents$237.4m, Q2 FY2026
Shareholders' equity$454.3m, Q2 FY2026
Line itemUnitperiod not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30period not labelled2025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reportednot reportednot reported88.0Cash and equivalents, period not labelled, at 2025-12-31$88.0m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure49.9Cash and equivalents, Q1 FY2026, at 2026-03-31$49.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure237Cash and equivalents, Q2 FY2026, at 2026-06-30$237.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Current assets$mnot reportednot reportednot reported193Current assets, period not labelled, at 2025-12-31$192.6m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure169Current assets, Q1 FY2026, at 2026-03-31$169.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure464Current assets, Q2 FY2026, at 2026-06-30$464.0m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Total assets$mnot reportednot reportednot reported195Total assets, period not labelled, at 2025-12-31$194.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure175Total assets, Q1 FY2026, at 2026-03-31$175.3m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure468Total assets, Q2 FY2026, at 2026-06-30$467.8m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Current liabilities$mnot reportednot reportednot reported10.7Current liabilities, period not labelled, at 2025-12-31$10.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure13.2Current liabilities, Q1 FY2026, at 2026-03-31$13.2m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure12.9Current liabilities, Q2 FY2026, at 2026-06-30$12.9m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Total liabilities$mnot reportednot reportednot reported11.3Total liabilities, period not labelled, at 2025-12-31$11.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure13.7Total liabilities, Q1 FY2026, at 2026-03-31$13.7m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure13.5Total liabilities, Q2 FY2026, at 2026-06-30$13.5m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure
Shareholders' equity$m(115)Shareholders' equity, period not labelled, at 2024-12-31−$115.3m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(129)Shareholders' equity, period not labelled, at 2025-03-31−$129.1m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(141)Shareholders' equity, period not labelled, at 2025-06-30−$141.5m. XBRL concept us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(177)Shareholders' equity, period not labelled, at 2025-12-31−$176.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure(199)Shareholders' equity, Q1 FY2026, at 2026-03-31−$198.6m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure454Shareholders' equity, Q2 FY2026, at 2026-06-30$454.3m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure

Cash flow

Operating cash flow−$22.6m, Q2 FY2026
Capital expenditure$23.0k, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(13.0)Operating cash flow, period not labelled, three months to 2025-03-31−$13.0m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(15.3)Operating cash flow, period not labelled, three months to 2025-06-30−$15.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344533. Derived: 6-month figure less the 3-month figure.Report this figure(21.6)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$21.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure(22.6)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$22.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-11, accession 0001193125-26-344533. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.0Capital expenditure, period not labelled, three months to 2025-03-31$16.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure0.0Capital expenditure, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344533. Derived: 6-month figure less the 3-month figure.Report this figure0.1Capital expenditure, Q1 FY2026, three months to 2026-03-31$112.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure0.0Capital expenditure, Q2 FY2026, three months to 2026-06-30$23.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-11, accession 0001193125-26-344533. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)30.11m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares0.9Diluted shares (weighted), period not labelled, three months to 2025-03-31946,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure0.9Diluted shares (weighted), period not labelled, three months to 2025-06-30946,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure0.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-31946,000 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-21, accession 0001193125-26-234386.Report this figure30.1Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3030,111,338 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure

Shares outstanding: 46.71mShares outstanding, period not labelled, at 2026-07-3146,712,117 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-11, accession 0001193125-26-344533.Report this figure at Jul 31, 2026, from the cover of the 10-Q filed Aug 11, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.